← Study Library
In vitro · 2009
Preclinicalcounts toward this tierResveratrol is not a direct activator of SIRT1 enzyme activity
Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L · Chemical Biology & Drug Design
Preclinicalcounts toward this tier
Resveratrol failed to activate SIRT1 against either a native p53 peptide or acetylated PGC-1alpha isolated from cells, in vitro or in cell-based assays; the untagged peptide was not even a substrate without its fluorophore. The authors concluded resveratrol's effects are unlikely to run through direct enzyme activation.
- Population
- Purified SIRT1 with p53-derived peptide and cell-derived acetylated PGC-1alpha
- Intervention
- Resveratrol
- Comparator
- Fluor de Lys tagged substrate
- Limitations
- In vitro; industry laboratory. Rules out one mechanism, not all of them.
Cited by
2 entries reference this study
- NMN / NAD+ precursorsPRECL.
Supplements → Vitamins & cofactors
- ResveratrolNOT SUPP.
Supplements → Anti-inflammatories